Just carried out a Google news search for "Dimerix" and came across an interesting article from just a few days ago. Interestingly the article has had over 800 views.
"A RECENT discovery by drug researchers whereby coupling specific cell membrane receptors has altered kidney cell function has triggered a re-think of how to treat chronic kidney disease (CKD) more effectively."............
..........."Together with colleagues in Melbourne they are recruiting CKD patients at the Austin Hospital for a clinical trial to test whether the combined use of two drugs that simultaneously target AT1 and CCR2 will improve their treatment."..........
..........."“We de-risk the discovery process very early on because the fundamental work can be done in a 96-well plate, testing receptor complexes in live cells,” he says."
SBN Price at posting:
1.1¢ Sentiment: Buy Disclosure: Held
